Welcome to LookChem.com Sign In|Join Free

CAS

  • or

314-35-2

Post Buying Request

314-35-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

314-35-2 Usage

Originator

Dalophylline,Arnolds Veterinary

Manufacturing Process

One mol of theophylline was dissolved in a 1% aqueous solution of 1 mol of caustic soda. One mol of β-diethylaminoethyl chloride was added, and the mixture was boiled for 6 hours with reflux, while stirring.The product was evaporated to dryness in vacuum, and the dry, pasty residue was taken up in acetone, to separate the desired compound from sodium chloride associated therewith. The acetone solution was distilled to remove solvent and 1,3-dimethyl-7-(β-diethylamino)ethylxanthine-7-(β- (diethylamino)ethyl)theophylline was obtained as a white mass. MP: 74°C. The product is very soluble in water, alcohol and acetone.

Therapeutic Function

Diuretic, Cardiotonic, Smooth muscle relaxant, Respiratory stimulant

Check Digit Verification of cas no

The CAS Registry Mumber 314-35-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,1 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 314-35:
(5*3)+(4*1)+(3*4)+(2*3)+(1*5)=42
42 % 10 = 2
So 314-35-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H21N5O2/c1-5-17(6-2)7-8-18-9-14-11-10(18)12(19)16(4)13(20)15(11)3/h9H,5-8H2,1-4H3

314-35-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-[2-(Diethylamino)ethyl]-1,3-dimethylxanthine

1.2 Other means of identification

Product number -
Other names Ditenate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:314-35-2 SDS

314-35-2Downstream Products

314-35-2Relevant articles and documents

Method for synthesizing mebendazole by means of methyl cyanocarbamate

-

Paragraph 0025-0042; 0051-0056, (2019/10/10)

The invention discloses a method for synthesizing mebendazole by means of methyl cyanocarbamate. The method comprises the steps that 3,4-diaminobenzophenone and methyl cyanocarbamate react in acetone and hydrochloric acid to prepare a crude mebendazole, the crude mebendazole forms salt in methyl alcohol-nitric acid to obtain mebendazole nitrate, and finally the mebendazole nitrate is subjected to crystal transformation in methyl alcohol-nitric acid to obtain C crystal type mebendazole. The cheap and easily-obtained 3,4-diaminobenzophenone and methyl cyanocarbamate are adopted as raw materials, a large quantity of waste salts generated in the O-methyl isourea methyl formate synthesis process are avoided, the cyclization time is short and only needs 4-6 h, the production period is remarkably shortened, high-salt wastewater by-products can be treated through simple distillation, and the good industrial prospect is achieved.

MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS

-

, (2016/09/22)

Mebendazole is an antiparasitic drug with over 40 years of safe use. Recently mebendazole was repurposed for glioblastoma therapy. Three polymorphs of mebendazole exist, but the relative polymorph content for existing drugs varies, and the therapeutic anti-cancer relevance of the different polymorphs was unknown. As an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations. Efficacy is further improved by combining mebendazole with a P-glycoprotein inhibitor. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.

DMSO-mediated ligand dissociation: Renaissance for biological activity of N-heterocyclic-[Ru(η6-arene)Cl2] drug candidates

Patra, Malay,Joshi, Tanmaya,Pierroz, Vanessa,Ingram, Katrin,Kaiser, Marcel,Ferrari, Stefano,Spingler, Bernhard,Keiser, Jennifer,Gasser, Gilles

, p. 14768 - 14772 (2013/11/06)

Slipped under the radar? 1HNMR spectroscopic examination revealed that [Ru(η6-arene)Cl2(L)] (L=N-heterocyclic ligands) complexes readily undergo a ligand exchange reaction in DMSO (see scheme), a popular medium for preparing stock solutions for biological screening. It is therefore highly important for researchers to study the stability in DMSO before reporting on the biological activity of such complexes. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 314-35-2